Microbiology of the skin and the role of biofilms in infection

International Wound Journal

Volumn 9, Issue 1, 2012, Pages 14-32

  Percival, Steven L ^a,b   Emanuel, Charlotte ^c   Cutting, Keith F ^d   Williams, David W ^c  

^a WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Advanced Medical Solutions Ltd   (United Kingdom)

^c CARDIFF UNIVERSITY   (United Kingdom)

^d BUCKINGHAMSHIRE NEW UNIVERSITY   (United Kingdom)

Author keywords

Bacteria; Biofilms; Micro organisms; Microflora; Skin

Indexed keywords

BETA DEFENSIN 2; CATHELICIDIN; CEFTRIAXONE; DAPTOMYCIN; FOSFOMYCIN; TIGECYCLINE;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; BIOFILM; CANDIDA ALBICANS; CORYNEBACTERIUM; DENATURING GRADIENT GEL ELECTROPHORESIS; ESCHERICHIA COLI; HUMAN; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; MALASSEZIA FOLLICULITIS; MICROBIAL COLONIZATION; MICROCOCCUS LUTEUS; MICROORGANISM DETECTION; MOISTURE; NONHUMAN; POPULATION ABUNDANCE; PRIORITY JOURNAL; PROPIONIBACTERIUM; PROPIONIBACTERIUM ACNES; PSEUDOMONAS AERUGINOSA; SKIN FLORA; SKIN INFECTION; SKIN SURFACE; SPECIES DISTRIBUTION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS LUGDUNENSIS; STRATUM CORNEUM; STREPTOCOCCUS PYOGENES; VERNIX CASEOSA; WOUND HEALING; WOUND INFECTION;

BACTERIAL INFECTIONS; BIOFILMS; COLONY COUNT, MICROBIAL; HUMANS; SKIN; WOUND INFECTION;

EID: 84862920857     PISSN: 17424801     EISSN: 1742481X     Source Type: Journal    
DOI: 10.1111/j.1742-481X.2011.00836.x     Document Type: Article

References (240)

1. Nizet V, Ohtake T, Lauth X, Trowbridge J, Rudisill J, Dorschner RA, Pestonjamasp V, Piraino J, Huttner K, Gallo RL. Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature 2001;414:454-7.
2. Schröder JM, Harder J. Antimicrobial skin peptides and proteins. Cell Mol Life Sci 2006;63:469-86.
3. Nobel WC. Carriage of micro-organisms on skin. In: Newsom SWB, Caldwell ADS, editors Problems in the control of hospital infection, International Congress and Symposium. Series No. 23. London: Academic Press, 1980.
4. Mackowiak PA. The normal microbial flora. N Engl J Med 1982;307:83-93.
5. Price PB. The bacteriology of normal skin; a new quantitative test applied to a study of the bacterial flora and disinfectant action of mechanical cleansing. J Infect Dis 1938;63:301-18.
6. Altoparlak U, Erol S, Akcay MN, Celebi F, Kadanali A. The time-related changes of antimicrobial resistance patterns and predominant bacterial profiles of burn wounds and body flora of burned patients. Burns 2004;30:660-4.
7. CDC Mass Casualties fact sheet, 2006. URL [accessed on May 2011].
8. Pruitt BA Jr, McManus AT, Kim SH, Goodwin CW. Burn wound infections: current status. World J Surg 1982;22:135-45.
9. Erol S, Altoparlak U, Akcay MN, Celebi F, Parlak M. Changes of microbial flora and wound colonization in burned patients. Burns 2004;30:357-61.
10. Cook N. Methicillin-resistant Staphylococcus aureus versus the burn patient. Burns 1998;24:91-8.
11. Taylor GD, Kibsey P, Kirkland T, Burroughs E, Tredget E. Predominance staphylococcal organisms in infections occurring occurring in a burns intensive care unit. Burns 1992;18:332-5.
12. Lesseva MI, Hadjiiski OG. Staphylococcal infections in the Sofia Burn Centre, Bulgaria. Burns 1996;22:279-82.
13. Santucci SG, Gobara S, Santos CR, Fontana C, Levin AS. Infections in a burn intensive care unit: experience of seven years. J Hosp Infect 2003;53:6-13.
14. Barak O, Treat JR, James WD. Antimicrobial peptides: effectors of innate immunity in the skin. Adv Dermatol 2005;21:357-74.
15. Elsner P. Antimicrobials and the skin physiological and pathological flora. Curr Probl Dermatol 2006;33:35-41.
16. Harder J, Schröder JM. Antimicrobial peptides in human skin. Chem Immunol Allergy 2005;86: 22-41.
17. Schauber J, Gallo RL. Antimicrobial peptides and skin immune defense system. J Allergy Clin Immunol 2009;124:13-8.
18. DiNardo A, Vitiello A, Gallo RL. Cutting edge: mast cell antimicrobial activity is mediated by expression of cathelicidin antimicrobial peptide. J Immunol 2003;170:2274-8.
19. Braff MH, Zaiou M, Fierer J, Nizet V, Gallo RL. Keratinocyte production of cathelicidin provides direct activity against bacterial skin pathogens. Infect Immun 2005;73:6771-81.
20. Cowland JB, Johnsen AH, Borregaard N. hCAP-18, a cathelin/pro-bactenecin-like protein of human neutrophil specific granules. FEBS Lett 1995;368:173-6.
21. Frohm M, Agerberth B, Ahangari G, Stâhle- Bäckdahl M, Lidén S, Wigzell H, Gudmundsson GH. The expression of the gene coding for the antibacterial peptide LL-37 is induced in human keratinocytes during inflammatory disorders. J Biol Chem 1997;272:15258-63.
22. Nelson A, Hultenby K, Hell E, Riedel HM, Brismar H, Flock JI, Lundahl J, Giske CG, Marchini G. Staphylococcus epidermidis isolated from newborn infants express pilus-like structures and are inhibited by the cathelicidin-derived antimicrobial peptide LL37. Pediatr Res 2009;66:174-8.
23. Oren A, Ganz T, Liu L, Meerloo T. In human epidermis, β-defensin 2 is packaged in lamellar bodies. Exp Mol Pathol 2003;74:180-2.
24. Lai Y, Cogen AL, Radek KA, Park HJ, Macleod DT, Leichtle A, Ryan AF, Di Nardo A, Gallo RL. Activation of TLR2 by a small molecule produced by Staphylococcus epidermidis increases antimicrobial defense against bacterial skin infections. J Invest Dermatol 2010;130:2211-21.
25. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature 2002;415:389-95.
26. Harder J, Bartels J, Christophers E, Schröder JM. A peptide antibiotic from human skin. Nature 1997;388:416.
27. Schittek B, Hipfel R, Sauer B, Bauer J, Kalbacher H, Stevanovic S, Schirle M, Schroeder K, Blin N, Meier F, Rassner G, Garbe C. Dermcidin: a novel human antibiotic peptide secreted by sweat glands. Nat Immunol 2011;2:1133-7.
28. Chen X, Niyonsaba F, Ushio H, Okuda D, Nagaoka I, Ikeda S, Okumura K, Ogawa H. Synergistic effect of antibacterial agents human beta-defensins, cathelicidin LL-37 and lysozyme against Staphylococcus aureus and Escherichia coli. J Dermatol Sci 2005;40:123-32.
29. Williamson P, Kligman AM. A new method for the quantitative investigation of cutaneous bacteria. J Invest Dermatol 1965;45:498-503.
30. Marples MJ. The ecology of human skin. Springfield, IL: Thomas CC Publisher, 1965.
31. Noble WC, Somerville CA. Microbiology of human skin. Philadelphia: Saunders WB Co Ltd., 1974: 50-76, 131, 212.
32. Kligman AM. The bacteriology of normal skin. In: Maibach HI, Hildick-Smith G, editors. Skin bacteria and their role in infection. New York: McGraw-Hill Book Co., 1965:13-31.
33. Wilburg J, Kasprowicz A, Heczko PB. Composition of normal bacterial flora of human skin in relation to the age and sex of examined persons. Przegl Dermatol 1984;71:551-7.
34. Larson EL, Cronquist AB, Whittier S, Lai L, Lyle CT, Della Latta P. Differences in skin flora between inpatients and chronically ill outpatients. Heart Lung 2000;29:298-305.
35. Rebel G, Pillsbury DM, Phalle G, et al. Factors affecting the rapid disappearance of bacteria placed on the normal flora. J Invest Dermatol 1950;14:247-63.
36. Hoath SB, Pickens WL, Visscher MO. The biology of vernix caseosa. Int J Cosmet Sci 2006;28: 319-33.
37. 2 and transepidermal water loss. J Invest Dermatol 1978;71:378-81.
38. Rissmann R, Oudshoorn MH, Zwier R, Ponec M, Bouwstra JA, Hennink WE. Mimicking vernix caseosa-preparation and characterization of synthetic biofilms. Int J Pharm 2009;372:59-65.
39. Akinbi HT, Narendran V, Pass AK, Markart P, Hoath SB. Host defense proteins in vernix caseosa and amniotic fluid. Am J Obstet Gynecol 2004;191:2090-6.
40. Marchini G, Lindow S, Brismar H, Ståbi B, Berggren V, Ulfgren AK, Lonne-Rahm S, Agerberth B, Gudmundsson GH. The newborn infant is protected by an innate antimicrobial barrier: peptide antibiotics are present in the skin and vernix caseosa. Br J Dermatol 2002;147: 1127-34.
41. Yoshio H, Tollin M, Gudmundsson GH, Lagercrantz H, Jornvall H, Marchini G, Agerberth B. Antimicrobial polypeptides of human vernix caseosa and amniotic fluid: implications for newborn innate defense. Pediatr Res 2003;53:211-16.
42. Kitzmiller JL, Highby S, Lucas WE. Retarded growth of E coli in amniotic fluid. Obstet Gynecol 1973;41:38-42.
43. Keyworth N, Millar MR, Holland KT. Development of cutaneous microflora in premature neonates. Arch Dis Child 1992;67:797-801.
44. Keyworth N, Millar MR, Holland KT. Swab-wash method for quantitation of cutaneous microflora. J Clin Microbiol 1990;28:941-3.
45. Kitajima H. Prevention of methicillin-resistant Staphylococcus aureus infections in neonates. Pediatr Int 2003;45:238-45.
46. Sarkany I, Gaylarde C. Skin flora of the newborn. The Lancet 1967;289:589-90.
47. Foca M, Jakob K, Whittier S, Della Latta P, Factor S, Rubenstein D, Saiman L. Endemic Pseudomonas aeruginosa infection in a neonatal intensive care unit. N Engl J Med 2000;343:695-700.
48. Lindberg E, Adlerberth I, Hesselmar B, Saalman R, Strannegård IL, Aberg N, Wold AE. High rate of transfer of Staphylococcus aureus from parental skin to infant gut flora. J Clin Microbiol 2004;42:530-4.
49. Cutland CL, Madhi SA, Zell ER, Kuwanda L, Laque M, Groome M, Gorwitz R, Thigpen MC, Patel R, Velaphi SC, Adrian P, Klugman K, Schuchat A, Schrag SJ; PoPS Trial Team. Chlorhexidine maternal-vaginal and neonate body wipes in sepsis and vertical transmission of pathogenic bacteria in South Africa: a randomised, controlled trial. Lancet 2009;374:1909-16.
50. da Cunha ML, Procianoy RS. Effect of bathing on skin flora of preterm newborns. J Perinatol 2005;25:375-9.
51. Joachim A, Matee MI, Massawe FA, Lyamuya EF. Maternal and neonatal colonisation of group B streptococcus at Muhimbili National Hospital in Dar es Salaam, Tanzania: prevalence, risk factors and antimicrobial resistance. BMC Public Health 2009;9:437.
52. Venkatesh MP, Placencia F, Weisman LE. Coagulase-negative staphylococcal infections in the neonate and child: an update. Semin Pediatr Infect Dis 2006;17:120-7.
53. Ashbee HR, Leck AK, Puntis JW, Parsons WJ, Evans EG. Skin colonisation by Malassezia in neonates and infants. Infect Control Hosp Epidemiol 2002;23:212-6.
54. Juncosa Morros T, González-Cuevas A, Alayeto Ortega J, Muñoz Almagro C, Moreno Hernando J, Gené Giralt A, Latorre Otín C. Cutaneous colonization by Malassezia spp. in neonates. An Esp Pediatr 2002;57:452-6.
55. Dekio I, Hayashi H, Sakamoto M, Kitahara M, Nishikawa T, Suematsu M, Benno Y. Detection of potentially novel bacterial components of the human skin microbiota using culture-independent molecular profiling. J Med Microbiol 2005;54:1231-8.
56. Gao Z, Tseng CH, Pei Z, Blaser MJ. Molecular analysis of human forearm superficial skin bacterial biota. Proc Natl Acad Sci U S A 2007;104:2927-32.
57. Harmory BH, Parisi JT. Staphylococcus epidermidis: a significant nosocomial pathogen. J Infect Control 1987;15:59-74.
58. Vuong C, Otto M. Staphylococcus epidermidis infections. Microbes Infect 2002;4:481-9.
59. Fekety FR Jr. The epidemiology and prevention of staphylococcal infection. Medicine 1964;43:593-613.
60. Nagase N, Sasaki A, Yamashita K, Shimizu A, Wakita Y, Kitai S, Kawano J. Isolation and species distribution of staphylococci from animal and human skin. J Vet Med Sci 2002;64:245-50.
61. Kloos WE. The identification of Staphylococcus and Micrococcus species isolated from human skin. In: Maibach HI, Aly R, editors. Skin microbiology: relevance to clinical infection. New York: Springer-Verlag, 1981.
62. Nobel WC. Microbiology of human skin. London: Lloyd-Luke (Medical Books) Ltd., 1981.
63. Kloos WE, Schleifer KH. Simplified scheme for routine identification of human Staphylococcus species. J Clin Microbiol 1975;1:82-8.
64. Till AE, Goulden V, Cunliffe WJ, Holland KT. The cutaneous microflora of adolescent, persistent and late-onset acne patients does not differ. Br J Dermatol 2000;142:885-92.
65. Mourelatos K, Eady EA, Cunliffe WJ, Clark SM, Cove JH. Temporal changes in sebum excretion and propionibacterial colonization in preadolescent children with and without acne. Br J Dermatol 2007;156:22-31.
66. Seifert H, Dijkshoorn L, Gerner-Smidt P, Pelzer N, Tjernberg I, Vaneechoutte M. Distribution of Acinetobacter species on human skin: comparison of phenotypic and genotypic identification methods. J Clin Microbiol 1997;53:2819-25.
67. Kloos WE, Musselwhite MS. Distribution and persistence of Staphylococcus and Micrococcus species and other aerobic bacteria on human skin. Appl Microbiol 1975;30:381-95.
68. Berlau J, Aucken H, Malnick H, Pitt T. Distribution of Acinetobacter species on skin of healthy humans. Eur J Clin Microbiol Infect Dis 1999;18:179-83.
69. Ashbee HR. Update on the genus Malassezia. Med Mycol 2007;45:287-303.
70. Paulino LC, Tseng CH, Strober BE, Blaser MJ. Molecular analysis of fungal microbiota in samples from healthy human skin and psoriatic lesions. J Clin Microbiol 2006;44:2933-41.
71. Gupta AK, Kohli Y. Prevalence of Malassezia species on various body sites in clinically healthy subjects representing different age groups. Med Mycol 2004;42:35-42.
72. Lee YW, Yim SM, Lim SH, Choe YB, Ahn KJ. Quantitative investigation on the distribution of Malassezia species on healthy human skin in Korea. Mycoses 2006;49:405-10.
73. Yim SM, Kim JY, Ko JH, Lee YW, Choe YB, Ahn KJ. Molecular analysis of malassezia microflora on the skin of the patients with atopic dermatitis. Ann Dermatol 2010;22:41-7.
74. Arzumanyan VG, Magarshak OO, Semenov BF. Yeast fungi in patients with allergic diseases: species variety and sensitivity to antifungal drugs. Bull Exper Biol Med 2000;129:601-4.
75. Aly R, Maibach HI. Aerobic microbial flora of intertrigenous skin. Appl Environ Microbiol 1977;33:97-100.
76. Bojar RA, Holland KT. The human cutaneous microbiota and factors controlling colonisation. World J Microbiol Biotechnol 2002;18:889-903.
77. Leyden JJ, McGinley KJ, Nordstrom KM, Webster GF. Skin microflora. J Invest Dermatol 1987;88:65s-72s.
78. Bieber L, Kahlmeter G. Staphylococcus lugdunensis in several niches of the normal skin flora. Clin Microbiol Infect 2010;16:385-8.
79. Evans CA, Crook JR, Strom MS. The bacterial flora of the forehead and back of Alaskan native villagers in summer and in winter. J Invest Dermatol 1984;82:294-7.
80. Webster GF. Skin microecology: the old and the new. Arch Dermatol 2007;143:105-6.
81. Somerville DA. The normal flora of the skin in different age groups. Mycopathologia 1980;71:85-7.
82. Selwyn S. Microbiology and ecology of human skin. Practitioner 1980;224:1059-62.
83. Huang JT, Abrams M, Tlougan B, Rademaker A, Paller AS. Treatment of Staphylococcus aureus colonization in atopic dermatitis decreases disease severity. Pediatrics 2009;123:e808-14.
84. Becker K, Roth R, Peters G. Rapid and specific detection of toxigenic Staphylococcus aureus: use of two multiplex PCR enzyme immunoassays for amplification and hybridization of staphylococcal enterotoxin genes, exfoliative toxin genes, and toxic shock syndrome toxin 1 gene. J Clin Microbiol 1998;36:2548-53.
85. Chung HJ, Jeon HS, Sung H, Kim MN, Hong SJ. Epidemiological characteristics of methicillin-resistant Staphylococcus aureus isolates from children with eczematous atopic dermatitis lesions. J Clin Microbiol 2008;46:991-5.
86. LeFrock JL, Ellis CA, Weinstein L. The impact of hospitalization on the aerobic fecal microflora. Am J Med Sci 1979;277:269-74.
87. Larson EL. Persistent carriage of Gram-negative bacteria on hands. Am J Infect Control 1981;9:112-9.
88. Chiller K, Selkin BA, Murakawa GJ. Skin microflora and bacterial infections of the skin. J Investig Dermatol Symp Proc 2001;6:170-4.
89. Platzek T, Lang C, Grohmann G, Gi US, Baltes W. Formation of a carcinogenic aromatic amine from an azo dye by human skin bacteria in vitro. Hum Exp Toxicol 1999;18:552-9.
90. Edlich RF, Winters KL, Britt LD, Long WB 3rd. Bacterial diseases of the skin. J Long Term Eff Med Implants 2005;15:499-510.
91. Roth RR, James WD. Microbiology of the skin: resident flora, ecology, infection. J Am Acad Dermatol 1989;20:367-90.
92. Fredricks DN. Microbial ecology of human skin in health and disease. J Investig Dermatol Symp Proc 2001;6:167-9.
93. Hadaway LC. Skin flora and infection. J Infusional Nursing 2003;26:44-8.
94. Hadaway LC. Skin flora: unwanted dead or alive. Nursing 2005;35:20.
95. Moellering RC Jr. The problem of complicated skin and skin structure infections: the need for new agents. J Antimicrob Chemother 2010;65(Suppl 4):iv3-8.
96. Diep BA, Gill SR, Chang RF, Phan TH, Chen JH, Davidson MG, Lin F, Lin J, Carleton HA, Mongodin EF, Sensabaugh GF, Perdreau-Remington F. Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus. Lancet 2006;367:731-9.
97. Grice EA, Kong HH, Conlan S, Deming CB, Davis J, Young AC; NISC Comparative Sequencing Program, Bouffard GG, Blakesley RW, Murray PR, Green ED, Turner ML, Segre JA. Topographical and temporal diversity of the human skin microbiome. Science 2009;324:1190-2.
98. Chih-Wei Lo, Yiu-Kay Lai, Yu-Tsueng Liu, Gallo Richard L, Huang Chun-Ming. Staphylococcus aureus hijacks a skin commensal to intensify its virulence: immunization targeting β-hemolysin and CAMP factor. J Invest Dermatol 2011;131:401-9.
99. von Eiff C, Peters G, Heilmann C. Pathogenesis of infections due to coagulase-negative staphylococci. Lancet Infect Dis 2002;2:677-85.
100. Diekema DJ, Pfaller MA, Schmitz FJ, Smayevsky J, Bell J, Jones RN, Beach M. Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin Infect Dis 2001; 32(2):S114-32.
101. Miller SI, Hoffman LR, Sanowar S. Did bacterial sensing of host environments evolve from sensing within microbial communities? Cell Host Microbe 2007;1:85-7.
102. Cogen AL, Nizet V, Gallo RL. Skin microbiota: a source of disease or defence? Br J Dermatol 2008;158:442-55.
103. Young VB, Schmidt TM. Overview of the gastrointestinal microbiota. Adv Exp Med Biol 2008;635:29-40.
104. Otto M. Staphylococcus epidermidis-the 'accidental' pathogen. Nat Rev Microbiol 2009;7:555-67.
105. Cogen AL, Nizet V, Gallo RL. Staphylococcus epidermidis functions as a component of the skin innate immune system by inhibiting the pathogen Group A Streptococcus. J Invest Dermatol 2007;127:S131.
106. Hanssen AM, Ericson Sollid JU. SCCmec in staphylococci: genes on the move. FEMS Immunol Med Microbiol 2006;46:8-20.
107. Hiramatsu K. Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance. Lancet Infect Dis 2001;1:147-55.
108. Suzuki E, Kuwahara-Arai K, Richardson JF, Hiramatsu K. Distribution of mec regulator genes in methicillin-resistant Staphylococcus clinical strains. Antimicrob Agents Chemother 1993;37: 1219-26.
109. Haque N, Bari MS Haque N, Khan RA, Haque S, Kabir MR, Yasmin T. Mymensingh Methicillin resistant Staphylococcus epidermidis. Med J 2011; 20(2):326-31.
110. Hajdu S, Lassnigg A, Graninger W, Hirschl AM, Presterl E. Effects of vancomycin, daptomycin, fosfomycin, tigecycline, and ceftriaxone on Staphylococcus epidermidis biofilms. J Orthop Res 2009;27:1361-5.
111. Mainous AG 3rd, Hueston WJ, Everett CJ, Diaz VA. Nasal carriage of Staphylococcus aureus and methicillin-resistant S. aureus in the United States, 2001-2002. Ann Fam Med 2006;4:132-7.
112. Lyon GJ, Novick RP. Peptide signaling in Staphylococcus aureus and other Gram-positive bacteria. Peptides 2004;25:1389-403.
113. von Eiff C, Becker K, Machka K, Stammer H, Peters G. Nasal carriage as a source of Staphylococcus aureus bacteremia. Study Group. N Engl J Med 2001;344:11-6.
114. Foster S. S. aureus: a 'superbug'. Microbiology Today 2008;35:18-21.
115. Maree CL, Daum RS, Boyle-Vavra S, Matayoshi K, Miller LG. Community-associated methicillin-resistant Staphylococcus aureus isolates causing healthcare-associated infections. Emerg Infect Dis 2007;13:236-42.
116. Elston JWT, Barlow GD. Community-associated MRSA in the United Kingdom. J Infect 2009;59:149-55.
117. Witte W. Community-acquired methicillin-resistant: what do we need to know? Clin Microbiol Infect Suppl 2009;7:17-25.
118. Holmes A, Ganner M, Mcguane S, Pitt TL, Cookson BD, Kearns AM. Staphylococcus aureus isolates carrying Panton-Valentine leucocidin genes in England and Wales: frequency, characterization, and association with clinical disease. J Clin Microbiol 2005;43:2384-90.
119. Ellington MJ, Hope R, Livermore DM, Kearns AM, Henderson K, Cookson BD, Pearson A, Johnson AP. Decline of EMRSA-16 amongst methicillin-resistant Staphylococcus aureus causing bacteraemias in the UK between 2001 and 2007. J Antimicrob Chemother 2010;65:446-8.
120. Bokarewa MI, Jin T, Tarkowski A. Staphylococcus aureus: Staphylokinase. Int J Biochem Cell Biol 2006;38:504-9.
121. Iwatsuki K, Yamasaki O, Morizane S, Oono T. Staphylococcal cutaneous infections: invasion, evasion and aggression. J Dermatol Sci 2006;42:203-14.
122. O'Neill GL, Murchan S, Gil-Setas A, Aucken HM. Identification and characterization of phage variants of a strain of epidemic methicillin-resistant Staphylococcus aureus (EMRSA-15). J Clin Microbiol 2001;39:1540-8.
123. Martinez-olondris P, Rigol M, Torres A. What lessons have been learnt from animal models of MRSA in the lung? Eur Respir J 2010;35:198-201.
124. Toledo-Arana A, Merino N, Vergara-Irigaray M, Debarbouille M, Penades JR, Lasa I. Staphylococcus aureus develops an alternative, ica-independent biofilm in the absence of the arlRS two-component system. J Bacteriol 2005;187: 5318-29.
125. Cohen AL, Shuler C, McAllister S, Fosheim GE, Brown MG, Abercrombie D, Anderson K, McDougal LK, Drenzek C, Arnold K, Jernigan D, Gorwitz R. Methamphetamine use and methicillin-resistant Staphylococcus aureus skin infections. Emerg Infect Dis 2007;13:1707-13.
126. Lina G, Piémont Y, Godail-Gamot F, Bes M, Peter M, Gauduchon V, Vandenesch F, Etienne J. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis 1999;29:1128-32.
127. Boyle-vavra S, Daum RS. Community-acquired methicillin-resistant Staphylococcus aureus: the role of Panton-Valentine leukocidin. Lab Invest 2007;87:3-9.
128. Otto M. Panton-Valentine leukocidin antibodies for the treatment of MRSA skin infections? Expert Rev Anti Infect Ther 2011;9:389-92.
129. Carré N, Herbreteau N, Askeur N, Dabas JP, Sillam F, Pinchon C, Bes M, Tristan A, Vandenesch F. Outbreak of skin infections due to Staphylococcus aureus carrying Panton-Valentine leukocidin genes in pupils and their relatives. Med Mal Infect 2011;41:364-71.
130. Del Giudice P, Bes M, Hubiche T, Blanc V, Roudière L, Lina G, Vandenesch F, Etienne J. Panton-valentine leukocidin-positive staphylococcus aureus strains are associated with follicular skin infections. Dermatology 2011;222(2): 167-70.
131. Moran GJ, Amii RN, Abrahamian FM, Talan DA. Methicillin-resistant Staphylococcus aureus in community-acquired skin infections. Emerg Infect Dis 2005;11:928-30.
132. Johnson JK, Khoie T, Shurland S, Kreisel K, Stine OC, Roghmann M. Skin and soft tissue infections caused by methicillin-resistant Staphylococcus aureus USA 300 clone. Emerg Infect Dis 2007;13:1195-200.
133. Tseng CW, Sanchez-Martinez M, Arruda A, Liu GY. Subcutaneous infection of methicillin resistant Staphylococcus aureus (MRSA). J Vis Exp 2011;9(48):2528.
134. Miller LG, Perdreau-Remington F, Rieg G, Mehdi S, Perlroth J, Bayer AS, Tang AW, Phung TO, Spellberg B. Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles. N Engl J Med 2005;352:1445-53.
135. Hageman JC, Uyeki TM, Francis JS. Severe community-acquired pneumonia due to Staphylococcus aureus, 2003-04 influenza season. Emerg Infect Dis 2006;12:894-9.
136. Seybold U, Kourbatova EV, Johnson JG, Halvosa SJ, Wang YF, King MD, Ray SM, Blumberg HM. Emergence of community-associated methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of health care-associated blood stream infections. Clin Infect Dis 2006;42:647-56.
137. Salvi GE, Furst MM, Lang NP, Persson GR. One-year bacterial colonization patterns of Staphylococcus aureus and other bacteria at implants and adjacent teeth. Clin Oral Implants Res 2008;19:242-8.
138. Zimmerli W. Ochsner PE. Management of infection associated with prosthetic joints. Infection 2003;31:99-108.
139. Arciola CR, Baldassarri L, Montanaro L. Presence of icaA and icaD genes and slime production in a collection of staphylococcal strains from catheter-associated infections. J Clin Microbiol 2001;39:2151-6.
140. Subramani K, Jung RE, Molenberg A, Hammerle CH. Biofilm on dental implants: a review of the literature. Int J Oral Maxillofac Implants 2009;24:616-26.
141. Yano K, Minoda Y, Sakawa A, Kuwano Y, Kondo K, Fukushima W, Tada K. Positive nasal culture of methicillin-resistant Staphylococcus aureus (MRSA) is a risk factor for surgical site infection in orthopedics. Acta Orthop 2009;80:486-90.
142. Fluckiger U, Ulrich M, Steinhuber A, Döring G, Mack D, Landmann R, Goerke C, Wolz C. Biofilm formation, icaADBC transcription, and polysaccharide intercellular adhesin synthesis by staphylococci in a device-related infection model. Infect Immun 2005;73:1811-9.
143. Freney J, Brun Y, Bes M, Meugnier H, Grimont F, Grimont PAD, Nervi C, Fleurette J. Staphylococcus lugdunensis sp nov and Staphylococcus schleiferi sp. nov., two species from human clinical specimens. Int J Syst Bacteriol 1988;38:168-72.
144. Herchline TE, Ayers LW. Occurrence of Staphylococcus lugdunensis in consecutive clinical cultures and relationship of isolation to infection. J Clin Microbiol 1991;29:419-42.
145. Frank KL, Del Pozo JL, Patel R. From clinical microbiology to infection pathogenesis: how daring to be different works for Staphylococcus lugdunensis. Clin Microbiol Rev 2008;21:111-33.
146. Patel R, Piper KE, Rouse MS, Uhl JR, Cockerill FRIII, Steckelberg JM. Frequency of isolation of Staphylococcus lugdunensis among staphylococcal isolates causing endocarditis: a 20-year experience. J Clin Microbiol 2000;38:4262-3.
147. Tena D, Aspiroz C, Figueras MJ, Gonzalez-Praetorius A, Aldea MJ, Alperi A, Bisquert J. Surgical site infection due to Aeromonas species: report of nine cases and literature review. Scand J Infect Dis 2009;41:164-70.
148. Arias M, Tena D, Apellániz M, Asensio MP, Caballero P, Hernández C, Tejedor F, Bisquert J. Skin and soft tissue infections caused by Staphylococcus lugdunensis: report of 20 cases. Scand J Infect Dis 2010;42:879-84.
149. Böcher S, Tønning B, Skov RL, Prag J. Staphylococcus lugdunensis, a common cause of skin and soft tissue infections in the community. Clin Microbiol 2009;47:946-50.
150. Hubiche T, Del Giudice P, Roudière L. Staphylococcus lugdunensis in skin infections: pathogen or colonizing bacterium? J Clin Microbiol 2009;47:3057.
151. Simões M. Antimicrobial strategies effective against infectious bacterial biofilms. Curr Med Chem 2011;18:2129-45.
152. Kristensen B, Schnheyder HC. A 13-year survey of bacteraemia due to beta-haemolytic streptococci in a Danish county. J Med Microbiol 1995;43:63-7.
153. Hindsholm M, Schønheyder HC. Clinical presentation and outcome of bacteraemia caused by beta-haemolytic streptococci serogroup G. Apmis 2002;110:554-8.
154. Brown J, Wannamaker LW, Ferrieri P. Enumeration of beta-haemolytic streptococci on normal skin by direct agar contact. J Med Microbiol 1975;8:503-12.
155. Rantala S, Vuopio-varkila J, Vuento R, Huhtala H, Syrjänen J. Clinical presentations and epidemiology of β-haemolytic streptococcal bacteraemia: a population-based study. Clin Microbiol Infect 2009;15:286-8.
156. Bang RL, Gang RK, Sanyal SC, Mokaddas EM, Lari AR. Beta-haemolytic Streptococcus infection in burns. Burns 1999;25:242-6.
157. Kaźmierczak AK, Szarapińska-Kwaszewska JK, Szewczyk EM. Opportunistic coryneform organisms-residents of human skin. Pol J Microbiol 2005;54:27-35.
158. Wichmann S, Wirsing von Koenig CH, Becker-Boost E, Finger H. Group JK corynebacteria in skin flora of healthy persons and patients. Eur J Clin Microbiol 1985;4:502-4.
159. Kaźmierczak AK, Szewczyk EM. Bacteria forming a resident flora of the skin as a potential source of opportunistic infections. Pol J Microbiol 2004;53:249-55.
160. Tancrede C. Role of human microflora in health and disease. Eur J Clin Microbiol Infect Dis 1992;11:1012-15.
161. McGinley KJ, Webster GF, Leyden JJ. Regional variations of cutaneous propionibacteria. Appl Environ Microbiol 1978;35:62-6.
162. Leyden JJ, McGinley KJ, Vowels B. Propionibacterium acnes colonization in acne and nonacne. Dermatology 1998;196:55-8.
163. Thiboutot DM. Overview of acne and its treatment. Cutis 2008;81(1 Suppl):3-7.
164. Yamada T, Eishi Y, Ikeda S, Ishige I, Suzuki T, Takemura T, Takizawa T, Koike M. In situ localization of Propionibacterium acnes DNA in lymph nodes from sarcoidosis patients by signal amplification with catalysed reporter deposition. J Pathol 2002;198:541-7.
165. Nishiwaki T, Yoneyama H, Eishi Y, Matsuo N, Tatsumi K, Kimura H, Kuriyama T, Matsushima K. Indigenous pulmonary Propionibacterium acnes primes the host in the development of sarcoid-like pulmonary granulomatosis in mice. Am J Pathol 2004;165:631-9.
166. Brüggemann H, Henne A, Hoster F, Liesegang H, Wiezer A, Strittmatter A, Hujer S, Dürre P, Gottschalk G. The complete genome sequence of Propionibacterium acnes, a commensal of human skin. Science 2004;305:671-3.
167. Zeller V, Ghorbani A, Strady C, Leonard P, Mamoudy P, Desplaces N. Propionibacterium acnes: an agent of prosthetic joint infection and colonization. J Infect 2007;55:119-24.
168. Williams RE, Doherty VR, Perkins W, Aitchison TC, Mackie RM. Staphylococcus aureus and intra-nasal mupirocin in patients receiving isotretinoin for acne. Br J Dermatol 1992;126: 362-6.
169. Ramage G, Tunney MM, Patrick S, Gorman SP, Nixon JR. Formation of Propionibacterium acnes biofilms on orthopaedic biomaterials and their susceptibility to antimicrobials. Biomaterials 2003;24:3221-7.
170. Bashir A, Mujahid TY, Jehan N. Antibiotic resistance profile: isolation and characterization of clinical isolates of staphylococci from patients with community-acquired skin infections. Pak J Pharm Sci 2007;20:299-304.
171. Duncan SF, Sperling JW. Treatment of primary isolated shoulder sepsis in the adult patient. Clin Orthop Relat Res 2008;466:1392-6.
172. Coenye T, Honraet K, Rossel B, Nelis HJ. Biofilms in skin infections: Propionibacterium acnes and acne vulgaris. Infect Disord Drug Targets 2008; 8:156-9.
173. Towner KJ. Acinetobacter: an old friend, but a new enemy. J Hosp Infect 2009;73:355-63.
174. Bergogne-Berezin E, Towner KJ. Acinetobacter spp as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin Micro Rev 1996;9:148-65.
175. Jawad A, Seifert H, Snelling AM, Heritage J, Hawkey PM. Survival of Acinetobacter baumannii on dry surfaces: comparison of outbreak and sporadic isolates. J Clin Microbiol 1998;36: 1938-41.
176. Wagenvoort JH, Joosten EJ. An outbreak Acinetobacter baumannii that mimics MRSA in its environmental longevity. J Hosp Infect 2002; 52:226-7.
177. Garnacho-Montero J, Amaya-Villar R. Multiresistant Acinetobacter baumannii infections: epidemiology and management. Curr Opin Infect Dis 2010;23:332-9.
178. Working Party HPA. 2008. URL [assessed on December 2010].
179. Marques MB, Waites KB, Mangino JE, Hines BB, Moser SA. Genotypic investigation of multidrug-resistant Acinetobacter baumannii infections in a medical intensive care unit. J Hosp Infect 1997;37:125-35.
180. Pimentel J, Low J, Styles K, Harris O, Hughes A, Athan E. Control of an outbreak of multi-drug-resistant in an intensive care unit and a surgical ward. Journal of Hospital Infection 2005;59:249-53.
181. Playford EG, Craig JC, Iredell JR. Carbapenem-resistant Acinetobacter baumannii in intensive care unit patients: risk factors for acquisition, infection and their consequences. J Hosp Infect 2007;65:204-11.
182. Enoch D, Summers C, Brown N, Moore L, Gillham M, Burnstein R, Thaxter R, Enoch L, Matta B, Sule O. Investigation and management of an outbreak of multidrug-carbapenem-resistant Acinetobacter baumannii in Cambridge, UK. J Hosp Infect 2008;70:109-18.
183. Chim H, Tan BH, Song C. Five-year review of infections in a burn intensive care unit: high incidence of Acinetobacter baumannii in a tropical climate. Burns 2007;33:1008-14.
184. Dallo SF, Weitao T. Insights into acinetobacter war-wound infections, biofilms, and control. Adv Skin Wound Care 2010;23:169-74.
185. Driscoll JA, Brody SL, Kollef MH. The epidemiology, pathogenesis and treatment of Pseudomonas aeruginosa infections. Drugs 2007;67:351-68.
186. Penz S, Puzenat E, Saccomani C, Mermet I, Blanc D, Humbert P, Aubin F. Locoregional polymorphous Pseudomonas aeruginosa skin infection. Med Mal Infect 2010;40:593-5.
187. Highsmith AK, Le PN, Khabbaz RF, Munn VP. Characteristics of Pseudomonas aeruginosa isolated from whirlpools and bathers. Infect Control 1985;6:407-12.
188. Breitenbach RA. Pseudomonas folliculitis from a health club whirlpool. Postgrad Med 1991;90:169-70.
189. Zichichi L, Asta G, Noto G. Pseudomonas aeruginosa folliculitis after shower/bath exposure. Int J Dermatol 2000;39:270-3.
190. Park DR. The microbiology of ventilator-associated pneumonia. Respir Care 2005;50:742-63.
191. Wu DC, Chan WW, Metelitsa AI, Fiorillo L, Lin AN. Pseudomonas skin infection: clinical features, epidemiology, and management. Am J Clin Dermatol 2011;12:157-69.
192. Romero R, Schaudinn C, Kusanovic JP, Gorur A, Gotsch F, Webster P, Nhan-Chang CL, Erez O, Kim CJ, Espinoza J, Gonçalves LF, Vaisbuch E, Mazaki-Tovi S, Hassan SS, Costerton JW. Detection of a microbial biofilm in intraamniotic infection. Am J Obstet Gynecol 2008;198:135.
193. Donlan RM, Costerton JW. Biofilms: survival mechanisms of clinically relevant micro-organisms. Clin Microbiol Rev 2002;15:167-93.
194. Mowad CM, McGinley KJ, Foglia A, Leyden JJ. The role of extracellular polysaccharide substance produced by Staphylococcus epidermidis in miliaria. J Am Acad Dermatol 1995;33:729-33.
195. Hu Y, Ulstrup J, Zhang J, Molin S, Dupres V. Adhesive properties of Staphylococcus epidermidis probed by atomic force microscopy. Phys Chem Chem Phys 2011;13(21):9995-10003.
196. Suzuki T, Kawamura Y, Uno T, Ohashi Y, Ezaki T. Prevalence of Staphylococcus epidermidis strains with biofilm-forming ability in isolates from conjunctiva and facial skin. Am J Ophthalmol 2005;140:844-50.
197. Schierle CF, De la Garza M, Mustoe TA, Galiano RD. Staphylococcal biofilms impair wound healing by delaying reepithelialization in a murine cutaneous wound model. Wound Repair Regen 2009;17:354-9.
198. Frank KL, Reichert EJ, Piper KE, Patel R. In vitro effects of antimicrobial agents on planktonic and biofilm forms of Staphylococcus lugdunensis clinical isolates. Antimicrob Agents Chemother 2007;51:888-95.
199. Burkhart CN, Burkhart CG. Microbiology's principle of biofilms as a major factor in the pathogenesis of acne vulgaris. Int J Dermatol 2003;42:925-7.
200. Patel A, Calfee RP, Plante M, Fischer SA, Green A. Propionibacterium acnes colonization of the human shoulder. J Shoulder Elbow Surg 2009; 18:897-902.
201. Holmberg A, Lood R, Mörgelin M, Söderquist B, Holst E, Collin M, Christensson B, Rasmussen M. Biofilm formation by Propionibacterium acnes is a characteristic of invasive isolates. Clin Microbiol Infect 2009;15:787-95.
202. Nobbs AH, Lamont RJ, Jenkinson HF. Streptococcus adherence and colonization. Microbiol Mol Biol Rev 2009;73:407-50.
203. Kwaszewska AK, Brewczyńska A, Szewczyk EM. Hydrophobicity and biofilm formation of lipophilic skin corynebacteria. Pol J Microbiol 2006;55:189-93.
204. Martin JM, Zenilman JM, Lazarus GS. Molecular microbiology: new dimensions for cutaneous biology and wound healing. J Invest Dermatol 2010;130:38-48.
205. Kirketerp-Møller K, Jensen PØ, Fazli M, Madsen KG, Pedersen J, Moser C, Tolker-Nielsen T, Høiby N, Givskov M, Bjarnsholt T. Distribution, organization, and ecology of bacteria in chronic wounds. J Clin Microbiol 2008;46:2717-22.
206. James GA, Swogger E, Wolcott R, Pulcini E, Secor P, Sestrich J, Costerton JW, Stewart PS. Biofilms in chronic wounds. Wound Repair Regen 2008;16:37-44.
207. Wolcott RD, Rhoads DD, Dowd SE. Biofilms and chronic wound inflammation. J Wound Care 2008;17:333-41.
208. Rowan NJ. Viable but non-culturable forms of food and waterborne bacteria: Quo Vadis? Trends Food Sci Technol 2004;15:462.
209. Wolcott RD, Kennedy JP, Dowd SE. Regular debridement is the main tool for maintaining a healthy wound bed in most chronic wounds. J Wound Care 2009;18:54-6.
210. Hill KE, Davies CE, Wilson MJ, Stephens P, Harding KG, Thomas DW. Molecular analysis of the microflora in chronic venous leg ulceration. J Med Microbiol 2003;52(Pt 4):365-9.
211. Dowd SE, Wolcott RD, Sun Y, McKeehan T, Smith E, Rhoads D. Polymicrobial nature of chronic diabetic foot ulcer biofilm infections determined using bacterial tag encoded FLX amplicon pyrosequencing (bTEFAP). PLoS ONE 2008;3:e3326.
212. Davies CE, Hill KE, Wilson MJ, Stephens P, Hill CM, Harding KG, Thomas DW. Use of 16S ribosomal DNA PCR and denaturing gradient gel electrophoresis for analysis of the microfloras of healing and nonhealing chronic venous leg ulcers. J Clin Microbiol 2004;42: 3549-57.
213. Dowd SE, Sun Y, Secor PR, Rhoads DD, Wolcott BM, James GA, Wolcott RD. Survey of bacterial diversity in chronic wounds using pyrosequencing, DGGE, and full ribosome shotgun sequencing. BMC Microbiol 2008;8:43.
214. Wolcott RD, Dowd SE. A rapid molecular method for characterising bacterial bioburden in chronic wounds. J Wound Care 2008;17:513-6.
215. Wolcott RD, Gontcharova V, Sun Y, Zischkau AM, Dowd SE. Bacterial diversity in surgical site infections: not just aerobic cocci any more. J Wound Care 2009;18:317-23.
216. Costerton JW, Lewandowski Z, Caldwell DE, Korber DR, Lappin-Scott HM. Microbial biofilms. Annu Rev Microbiol 1995;49:711-45.
217. Athanasopoulos AN, Economopoulou M, Orlova VV, Sobke A, Schneider D, Weber H, Augustin HG, Eming SA, Schubert U, Linn T, Nawroth PP, Hussain M, Hammes HP, Herrmann M, Preissner KT, Chavakis T. The extracellular adherence protein (Eap) of Staphylococcus aureus inhibits wound healing by interfering with host defense and repair mechanisms. Blood 2006;107:2720-7.
218. Gontcharova V, Youn E, Sun Y, Wolcott RD, Dowd SE. A comparison of bacterial composition in diabetic ulcers and contralateral intact skin. Open Microbiol J 2010;4:8-19.
219. Westgate SJ, Percival SL, Knottenbelt DC, Clegg PD, Cochrane CA. Microbiology of equine wounds and evidence of bacterial biofilms. Vet Microbiol 2011;150:152-9.
220. Bjarnsholt T, Kirketerp-Møller K, Jensen PØ, Madsen KG, Phipps R, Krogfelt K, Høiby N, Givskov M. Why chronic wounds will not heal: a novel hypothesis. Wound Repair Regen 2008;16:2-10.
221. Wolcott RD, Rhoads DD. A study of biofilm-based wound management in subjects with critical limb ischaemia. J Wound Care 2008;17:145-55.
222. Percival SL, Cutting KF. Biofilms: possible strategies for suppression in chronic wounds. Nurs Stand 2009;66:15-21; 23(32):64, 68, passim.
223. Percival SL, Bowler P, Woods EJ. Assessing the effect of an antimicrobial wound dressing on biofilms. Wound Repair Regen 2008;16:52-7.
224. Wolcott R, Cutting K, Dowd S, Percival SL. Surgical site infections: biofilms, dehiscence and wound healing. US dermatology touch briefings 2008; 56-9.
225. Percival SL, Thomas J, Williams D. Biofilms and bacterial imbalances in chronic wounds: anti-Koch. Int Wound J 2010;7:169-75.
226. Roth RR, James WD. Microbial ecology of the skin. Annu Rev Microbiol 1988;42:441-64.
227. Krutmann J. Pre- and probiotics for human skin. J Dermatol Sci 2009;54:1-5.
228. Hansson C, Hoborn J, Moller A, Swanbeck G. The microbial flora in venous leg ulcers without clinical signs of infection. Repeated culture using a validated standardised microbiological technique. Acta Derm Venereol 1995;75:24-30.
229. Tauch A, Kaiser O, Hain T, Goesmann A, Weisshaar B, Albersmeier A, Bekel T, Bischoff N, Brune I, Chakraborty T, Kalinowski J, Meyer F, Rupp O, Schneiker S, Viehoever P, Pühler A. Complete genome sequence and analysis of the multiresistant nosocomial pathogen Corynebacterium jeikeium K411, a lipid-requiring bacterium of the human skin flora. J Bacteriol 2005; 187:4671-82.
230. Viswanathan V. Epidemiology of diabetic foot and management of foot problems in India. Int J Low Extrem Wounds 2010;9:122-6.
231. Brook I, Frazier EH. Aerobic and anaerobic microbiology of chronic venous ulcers. Int J Dermatol 1998;37:426-8.
232. Sun Y, Smith E, Wolcott R, Dowd SE. Propagation of anaerobic bacteria within an aerobic multi-species chronic wound biofilm model. J Wound Care 2009;18:426-31.
233. Kontiainen S, Rinne E. Bacteria in ulcera crurum. Acta Derm Venereol 1988;68:240-4.
234. Howell-Jones RS, Wilson MJ, Hill KE, Howard AJ, Price PE, Thomas DW. A review of the microbiology, antibiotic usage and resistance in chronic skin wounds. J Antimicrob Chemother 2005;55:143-9.
235. Bradshaw DJ, Marsh PD, Watson GK, Allison C. Role of Fusobacterium nucleatum and coaggregation in anaerobe survival in planktonic and biofilm oral microbial communities during aeration. Infect Immun 1998;66:4729-32.
236. Bradshaw DJ, Marsh PD, Allison C, Schilling KM. Effect of oxygen, inoculum composition and flow rate on development of mixed-culture oral biofilms. Microbiology 1996;142:623-9.
237. Rasmussen K, Lewandowski Z. Microelectrode measurements of local mass transport rates in heterogeneous biofilms. Biotechnol Bioeng 1998;59:302-9.
238. Bevins CL. An important clue: fingerprints point to psoriasin in defense against E. coli. Nat Immunol 2005;6:12-3.
239. Baumann L, Weisberg E, Percival SL. Skin ageing and microbiology. In: Percival SL, editor. Microbiology and aging. New York: Humana Press, 2009.
240. Cooper R, Percival SL. Human skin and microflora. In: Percival SL, Cutting K, editors. Microbiology of wounds. New York: CRC Press, 2010.